126 related articles for article (PubMed ID: 17706924)
1. Heterooligomerization of human dopamine receptor 2 and somatostatin receptor 2 Co-immunoprecipitation and fluorescence resonance energy transfer analysis.
Baragli A; Alturaihi H; Watt HL; Abdallah A; Kumar U
Cell Signal; 2007 Nov; 19(11):2304-16. PubMed ID: 17706924
[TBL] [Abstract][Full Text] [Related]
2. Agonist-dependent dissociation of human somatostatin receptor 2 dimers: a role in receptor trafficking.
Grant M; Collier B; Kumar U
J Biol Chem; 2004 Aug; 279(35):36179-83. PubMed ID: 15231824
[TBL] [Abstract][Full Text] [Related]
3. Porcine somatostatin receptor 2 displays typical pharmacological sst2 features but unique dynamics of homodimerization and internalization.
Durán-Prado M; Bucharles C; Gonzalez BJ; Vázquez-Martínez R; Martínez-Fuentes AJ; García-Navarro S; Rhodes SJ; Vaudry H; Malagón MM; Castaño JP
Endocrinology; 2007 Jan; 148(1):411-21. PubMed ID: 17053026
[TBL] [Abstract][Full Text] [Related]
4. The role of subtype-specific ligand binding and the C-tail domain in dimer formation of human somatostatin receptors.
Grant M; Patel RC; Kumar U
J Biol Chem; 2004 Sep; 279(37):38636-43. PubMed ID: 15247250
[TBL] [Abstract][Full Text] [Related]
5. Allosteric interactions between agonists and antagonists within the adenosine A2A receptor-dopamine D2 receptor heterotetramer.
Bonaventura J; Navarro G; Casadó-Anguera V; Azdad K; Rea W; Moreno E; Brugarolas M; Mallol J; Canela EI; Lluís C; Cortés A; Volkow ND; Schiffmann SN; Ferré S; Casadó V
Proc Natl Acad Sci U S A; 2015 Jul; 112(27):E3609-18. PubMed ID: 26100888
[TBL] [Abstract][Full Text] [Related]
6. Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity.
Rocheville M; Lange DC; Kumar U; Patel SC; Patel RC; Patel YC
Science; 2000 Apr; 288(5463):154-7. PubMed ID: 10753124
[TBL] [Abstract][Full Text] [Related]
7. Antidepressant drugs promote the heterodimerization of the dopamine D2 and somatostatin Sst5 receptors--fluorescence in vitro studies.
Szafran K; Lukasiewicz S; Faron-Górecka A; Kolasa M; Kuśmider M; Solich J; Dziedzicka-Wasylewska M
Pharmacol Rep; 2012; 64(5):1253-8. PubMed ID: 23238481
[TBL] [Abstract][Full Text] [Related]
8. Coexpression of somatostatin receptor subtype 5 affects internalization and trafficking of somatostatin receptor subtype 2.
Sharif N; Gendron L; Wowchuk J; Sarret P; Mazella J; Beaudet A; Stroh T
Endocrinology; 2007 May; 148(5):2095-105. PubMed ID: 17272399
[TBL] [Abstract][Full Text] [Related]
9. Agonist-dependent internalization of D2 receptors: Imaging quantification by confocal microscopy.
Goggi JL; Sardini A; Egerton A; Strange PG; Grasby PM
Synapse; 2007 Apr; 61(4):231-41. PubMed ID: 17230553
[TBL] [Abstract][Full Text] [Related]
10. A new D₂ dopamine receptor agonist allosterically modulates A(2A) adenosine receptor signalling by interacting with the A(2A)/D₂ receptor heteromer.
Trincavelli ML; Daniele S; Orlandini E; Navarro G; Casadó V; Giacomelli C; Nencetti S; Nuti E; Macchia M; Huebner H; Gmeiner P; Rossello A; Lluís C; Martini C
Cell Signal; 2012 Apr; 24(4):951-60. PubMed ID: 22230688
[TBL] [Abstract][Full Text] [Related]
11. Subtypes of the somatostatin receptor assemble as functional homo- and heterodimers.
Rocheville M; Lange DC; Kumar U; Sasi R; Patel RC; Patel YC
J Biol Chem; 2000 Mar; 275(11):7862-9. PubMed ID: 10713101
[TBL] [Abstract][Full Text] [Related]
12. Cocaine produces D2R-mediated conformational changes in the adenosine A(2A)R-dopamine D2R heteromer.
Marcellino D; Navarro G; Sahlholm K; Nilsson J; Agnati LF; Canela EI; Lluís C; Århem P; Franco R; Fuxe K
Biochem Biophys Res Commun; 2010 Apr; 394(4):988-92. PubMed ID: 20307491
[TBL] [Abstract][Full Text] [Related]
13. Aplindore (DAB-452), a high affinity selective dopamine D2 receptor partial agonist.
Heinrich JN; Brennan J; Lai MH; Sullivan K; Hornby G; Popiolek M; Jiang LX; Pausch MH; Stack G; Marquis KL; Andree TH
Eur J Pharmacol; 2006 Dec; 552(1-3):36-45. PubMed ID: 17056032
[TBL] [Abstract][Full Text] [Related]
14. Neurochemical and functional characterization of the preferentially selective dopamine D3 agonist PD 128907.
Pugsley TA; Davis MD; Akunne HC; MacKenzie RG; Shih YH; Damsma G; Wikstrom H; Whetzel SZ; Georgic LM; Cooke LW
J Pharmacol Exp Ther; 1995 Dec; 275(3):1355-66. PubMed ID: 8531103
[TBL] [Abstract][Full Text] [Related]
15. D1 and D2 dopamine receptors form heterooligomers and cointernalize after selective activation of either receptor.
So CH; Varghese G; Curley KJ; Kong MM; Alijaniaram M; Ji X; Nguyen T; O'dowd BF; George SR
Mol Pharmacol; 2005 Sep; 68(3):568-78. PubMed ID: 15923381
[TBL] [Abstract][Full Text] [Related]
16. Ovine placental lactogen-induced heterodimerization of ovine growth hormone and prolactin receptors in living cells is demonstrated by fluorescence resonance energy transfer microscopy and leads to prolonged phosphorylation of signal transducer and activator of transcription (STAT)1 and STAT3.
Biener E; Martin C; Daniel N; Frank SJ; Centonze VE; Herman B; Djiane J; Gertler A
Endocrinology; 2003 Aug; 144(8):3532-40. PubMed ID: 12865335
[TBL] [Abstract][Full Text] [Related]
17. Activation of adenylate cyclase by human recombinant sst5 receptors expressed in CHO-K1 cells and involvement of Galphas proteins.
Carruthers AM; Warner AJ; Michel AD; Feniuk W; Humphrey PP
Br J Pharmacol; 1999 Mar; 126(5):1221-9. PubMed ID: 10205012
[TBL] [Abstract][Full Text] [Related]
18. Photobleaching fluorescence resonance energy transfer reveals ligand-induced oligomer formation of human somatostatin receptor subtypes.
Patel RC; Lange DC; Patel YC
Methods; 2002 Aug; 27(4):340-8. PubMed ID: 12217650
[TBL] [Abstract][Full Text] [Related]
19. Co-operativity in agonist binding at the D2 dopamine receptor: evidence from agonist dissociation kinetics.
Kara E; Lin H; Strange PG
J Neurochem; 2010 Mar; 112(6):1442-53. PubMed ID: 20050980
[TBL] [Abstract][Full Text] [Related]
20. Somatostatin and dopamine receptor interaction in prostate and lung cancer cell lines.
Arvigo M; Gatto F; Ruscica M; Ameri P; Dozio E; Albertelli M; Culler MD; Motta M; Minuto F; Magni P; Ferone D
J Endocrinol; 2010 Dec; 207(3):309-17. PubMed ID: 20876239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
